Belite Bio, Inc American Depositary Shares
BLTE
$193.61
+13.16%
BLTE
Belite Bio, Inc American Depositary Shares
$193.61
BLTE price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Belite Bio, Inc American Depositary Shares's 12-month outlook, with a consensus price target around $214.00 and implied upside of +10.5% versus the current price.
Average Target
$214.00
0 analysts
Implied Upside
+10.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$185 - $270
Analyst target range
BLTE Technical Analysis
Beta
-1.23
-1.23x market volatility
Max Drawdown
-29.1%
Largest decline past year
52-Week Range
$65-$200
Price range past year
Annual Return
+197.2%
Cumulative gain past year
| Period | BLTE Return | S&P 500 |
|---|---|---|
| 1m | +22.2% | +0.1% |
| 3m | +35.1% | +4.4% |
| 6m | +11.7% | +14.6% |
| 1y | +197.2% | +18.6% |
| ytd | +21.6% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is BLTE Overvalued?
PE
-69.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-65.0x
Enterprise Value Multiple